Related Experiment Video
Updated: Aug 25, 2026

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
Published on: February 23, 2024
Sideroblastic anaemia during fusidic acid treatment
1Centre Antipoison-Centre de Pharmacovigilance de Lyon, 162 avenue Lacassagne, 69424 Lyon, France. thierry.vial@chu-lyon.fr
Objectives And Methods:
To describe cases of fusidic acid-associated sideroblastic anaemia from the French Pharmacovigilance database.
Results:
Six cases of sideroblastic anaemia associated with oral fusidic acid treatment were retrieved. Four females and two males (mean age 65.3 yr) developed severe anaemia (mean haemoglobin level: 6.9 g/dL) within 32-190 d (mean: 81 d) of treatment. Bone marrow aspirates showed dyserythropoiesis and ringed sideroblasts in all patients. Four patients required repeated blood transfusions. After fusidic acid discontinuation in five patients, complete recovery was obtained. In one patient, rechallenge with fusidic acid resulted in recurrence of anaemia that resolved after definitive discontinuation of the drug.
Conclusion:
Our data indicate that fusidic acid should be added to the list of drugs that can cause sideroblastic anaemia.
Related Concept Videos
Antiprotozoal Agents
Acid Mine Drainage
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Rocky Mountain Spotted Fever
Drugs for Treatment of Ulcerative Colitis in IBD
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...